IgM and IgG antibodies to hepatitis C virus in patients with mixed cryoglobulinaemia.

Por L'Abbate, A, Cutrupi, S, Rognetta, M, Fabiano, C, Craxi, A
Publicado em 1993

Autoimmunity in chronic liver disease caused by hepatitis delta virus.

Por Zauli, D, Crespi, C, Bianchi, F B, Craxi, A, Pisi, E
Publicado em 1986

Fatal hepatic decompensation associated with interferon alfa. European concerted action on viral hepatitis (Eurohep).

Por Janssen, H. L., Brouwer, J. T., Nevens, F., Sanchez-Tapias, J. M., Craxi, A., Hadziyannis, S.
Publicado em 1993

Effects of prednisolone/azathioprine in chronic hepatitis B viral infection.

Por Weller, I V, Bassendine, M F, Murray, A K, Craxi, A, Thomas, H C, Sherlock, S
Publicado em 1982

Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).

Por Weller, I V, Bassendine, M F, Craxi, A, Fowler, M J, Monjardino, J, Thomas, H C, Sherlock, S
Publicado em 1982

Relationship between HBV-specific DNA polymerase and HBe antigen/antibody system in chronic HBV infection: factors determining selection of patients and outcome of antiviral therap...

Por Craxi, A, Weller, I V, Bassendine, M F, Fowler, M J, Monjardino, J, Thomas, H C, Sherlock, S
Publicado em 1983

Immunoblotting as a confirmatory test for antimitochondrial antibodies in primary biliary cirrhosis.

Por Provenzano, G, Diquattro, O, Craxì, A, Almasio, P, Pinzello, G, Marino, L, Fiorentino, G, Rinaldi, F, Pagliaro, L
Publicado em 1993

Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease.

Por Craxì, A, Raimondo, G, Longo, G, Giannuoli, G, De Pasquale, R, Caltagirone, M, Patti, S, Squadrito, G, Pagliaro, L
Publicado em 1984

Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis

Por Fiorica, F, Di Bona, D, Schepis, F, Licata, A, Shahied, L, Venturi, A, Falchi, A M, Craxì, A, Cammà, C
Publicado em 2004

Alexithymia and personality traits of patients with inflammatory bowel disease

Por La Barbera, D., Bonanno, B., Rumeo, M. V., Alabastro, V., Frenda, M., Massihnia, E., Morgante, M. C., Sideli, L., Craxì, A., Cappello, M., Tumminello, M., Miccichè, S., Nastri, L.
Publicado no Sci Rep (2017)

Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis

Por Gramenzi, A, Andreone, P, Fiorino, S, Camma, C, Giunta, M, Magalotti, D, Cursaro, C, Calabrese, C, Arienti, V, Rossi, C, Di, F, Zoli, M, Craxi, A, Gasbarrini, G, Bernardi, M
Publicado em 2001

IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection

Por O'Connor, K S, Read, S A, Wang, M, Schibeci, S, Eslam, M, Ong, A, Weltman, M D, Douglas, M W, Mazzola, A, Craxì, A, Petta, S, Stewart, G J, Liddle, C, George, J, Ahlenstiel, G, Booth, D R
Publicado no Genes Immun (2016)

Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data

Por Cammà, C, Bruno, S, Schepis, F, Lo Iacono, O, Andreone, P, Gramenzi, A G, Mangia, A, Andriulli, A, Puoti, M, Spadaro, A, Freni, M, Di Marco, V, Cino, L, Saracco, G, Chiesa, A, Crosignani, A, Caporaso, N, Morisco, F, Rumi, M G, Craxì, A
Publicado em 2002